Author:
Imoto Issei,Yamamoto Mitsuyoshi,Jia Dong Mei,Otsuki Makoto
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Silverman MA, Greenberg RE, Bank S. Cholecystokinin receptor antagonist.Am J Gastroenterol 1987; 82: 703–708.
2. Rovati LC. Perspectives of CCK antagonists in pancreatic research and clinical use.Int J Pancreatol 1991; 8: 215–226.
3. Takacs T, Pap A. Perspectives of CCK antagonists in pancreatic research. Part II. Experimental studies.Int J Pancreatol 1991; 10: 1–8.
4. Niederau C, Liddle RA, Ferrell LD, Grendell JH. Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis.J Clin Invest 1986; 78: 1056–1063.
5. Setnikar I, Bani M, Cereda R, Chiste R, Makovec F, Pacini MA, Revel L. Loxiglumide protects against experimental pancreatitis.Arzneim-Forsch Drug Res 1987; 37: 1172–1174.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献